186
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Efficacy and safety of ubrogepant for migraine: a meta-analysis of randomized controlled studies

&
Pages 124-130 | Received 03 Jan 2022, Accepted 10 Jun 2022, Published online: 26 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bing Cao, Shanshan Gu, Zhisen Shen, Yuna Zhang, Yiming Shen & Hang Chen. (2023) Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system. Expert Opinion on Drug Safety 0:0, pages 1-7.
Read now
János Tajti, Délia Szok, Anett Csáti & László Vécsei. (2023) The pharmacotherapeutic management of episodic and chronic migraine with gepants. Expert Opinion on Pharmacotherapy 24:8, pages 947-958.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.